Sodium-glucose cotransporters: Functional properties and pharmaceutical potential

被引:112
作者
Sano, Ryuhei [1 ]
Shinozaki, Yuichi [1 ]
Ohta, Takeshi [2 ]
机构
[1] Japan Tobacco Inc, Biol Pharmacol Res Labs, Cent Pharmaceut Res Inst, Takatsuki, Osaka, Japan
[2] Kyoto Univ, Lab Anim Physiol & Funct Anat, Grad Sch Agr, Kyoto, Japan
关键词
Antidiabetic drugs; Sodium-glucose cotransporter 1; Sodium-glucose cotransporter 2; SGLT2 INHIBITOR EMPAGLIFLOZIN; AFFINITY NA+/GLUCOSE COTRANSPORTER; IMPROVED GLYCEMIC CONTROL; POSTPRANDIAL HYPERGLYCEMIA; DIABETIC-NEPHROPATHY; SELECTIVE INHIBITOR; TISSUE DISTRIBUTION; SUGAR TRANSPORTER; GENE-EXPRESSION; CARRIER SGLT1;
D O I
10.1111/jdi.13255
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucose is the most abundant monosaccharide, and an essential source of energy for most living cells. Glucose transport across the cell membrane is mediated by two types of transporters: facilitative glucose transporters (gene name: solute carrier 2A) and sodium-glucose cotransporters (SGLTs; gene name: solute carrier 5A). Each transporter has its own substrate specificity, distribution, and regulatory mechanisms. Recently, SGLT1 and SGLT2 have attracted much attention as therapeutic targets for various diseases. This review addresses the basal and functional properties of glucose transporters and SGLTs, and describes the pharmaceutical potential of SGLT1 and SGLT2.
引用
收藏
页码:770 / 782
页数:13
相关论文
共 135 条
[1]   Renal protective effect of SGLT2 inhibitor dapagliflozin alone and in combination with irbesartan in a rat model of diabetic nephropathy [J].
Abdel-Wahab, Ali F. ;
Bamagous, Ghazi A. ;
Al-Harizy, Randa M. ;
ElSawy, Naser A. ;
Shahzad, Naiyer ;
Ibrahim, Ibrahim A. ;
Al Ghamdi, Saeed S. .
BIOMEDICINE & PHARMACOTHERAPY, 2018, 103 :59-66
[2]   Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus [J].
Abdul-Ghani, Muhammad A. ;
Norton, Luke ;
DeFronzo, Ralph A. .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2015, 309 (11) :F889-F900
[3]   Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30-50% of Filtered Glucose Load in Humans [J].
Abdul-Ghani, Muhammad A. ;
DeFronzo, Ralph A. ;
Norton, Luke .
DIABETES, 2013, 62 (10) :3324-3328
[4]   Effects of combination of mitiglinide with various oral antidiabetic drugs in streptozotocin-nicotinamide-induced type 2 diabetic rats and Zucker fatty rats [J].
Akahane, Kenji ;
Ojima, Kazuma ;
Yokoyama, Ayaka ;
Inoue, Toshihiro ;
Kiguchi, Sumiyoshi ;
Tatemichi, Satoshi ;
Takeda, Hiroo ;
Imai, Yohsuke .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2017, 44 (12) :1263-1271
[5]   Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans [J].
Anzai, Naohiko ;
Ichida, Kimiyoshi ;
Jutabha, Promsuk ;
Kimura, Toru ;
Babu, Ellappan ;
Jin, Chun Ji ;
Srivastava, Sunena ;
Kitamura, Kenichiro ;
Hisatome, Ichiro ;
Endou, Hitoshi ;
Sakurai, Hiroyuki .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (40) :26834-26838
[6]   Androgen Suppresses Corticotropin-Induced Increase in Plasma Cortisol Level but Enhances The Increase in Plasma Aldosterone Level in Goats [J].
Aoyama, Masato ;
Maejima, Yuko ;
Suzuki, Toshio ;
Iigo, Masayuki ;
Sugita, Shoei .
JOURNAL OF VETERINARY MEDICAL SCIENCE, 2009, 71 (03) :281-285
[7]   Glucose uptake via SGLT-1 is stimulated by β2-adrenoceptors in the ruminal epithelium of sheep [J].
Aschenbach, JR ;
Borau, T ;
Gäbel, G .
JOURNAL OF NUTRITION, 2002, 132 (06) :1254-1257
[8]   Identification and characterization of human glucose transporter-like protein-9 (GLUT9) - Alternative splicing alters trafficking [J].
Augustin, R ;
Carayannopoulos, MO ;
Dowd, LO ;
Phay, JE ;
Moley, JF ;
Moley, KH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (16) :16229-16236
[9]   Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody [J].
Balen, Daniela ;
Ljubojevic, Marija ;
Breljak, Davorka ;
Brzica, Hrvoje ;
Zlender, Vilim ;
Koepsell, Hermann ;
Sabolic, Ivan .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2008, 295 (02) :C475-C489
[10]   SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy [J].
Banerjee, Sanjay K. ;
Wang, David W. ;
Alzamora, Rodrigo ;
Huang, Xueyin N. ;
Pastor-Soler, Nuria M. ;
Hallows, Kenneth R. ;
McGaffin, Kenneth R. ;
Ahmad, Ferhaan .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2010, 49 (04) :683-692